DKF-313

DRUG2 trials

Sponsors

Dongkook Pharmaceutical Co., Ltd.

Conditions

Benign Prostate HyperplasiaBenign Prostatic HyperplasiaHealthy

Phase 1

Safety and Pharmacokinetic Characteristics of DKF-313

CompletedNCT02352311

Dongkook Pharmaceutical Co., Ltd.Benign Prostate Hyperplasia, Healthy

Start: 2015-01-31End: 2015-06-30Updated: 2021-07-06

Phase 3

Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia

CompletedNCT04947631

Dongkook Pharmaceutical Co., Ltd.Benign Prostatic Hyperplasia

Start: 2021-07-27End: 2023-06-12Updated: 2023-09-21